Evidence map›Paper›PMID 41111659›Full record

ArticleCureus2025

Sequential Development of Iliopsoas Hematoma and Abscess in an Elderly Patient With COVID-19: A Case Report.

Kazusa Hirokane, Natsumi Yamamoto, Shiho Amano, Kurumi Kasai, Ryuichi Ohta

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kazusa HirokaneCommunity Care, Unnan City Hospital, Unnan, JPN.
Natsumi YamamotoCommunity Care, Unnan City Hospital, Unnan, JPN.
Shiho AmanoCommunity Care, Unnan City Hospital, Unnan, JPN.
Kurumi KasaiCommunity Care, Unnan City Hospital, Unnan, JPN.
Ryuichi OhtaCommunity Care, Unnan City Hospital, Unnan, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iliopsoas hematoma and iliopsoas abscess are rare but serious conditions that may complicate the course of elderly patients with COVID-19. The infection itself, along with corticosteroids, anticoagulation, and other immunosuppressive therapies used in treatment, can increase susceptibility to both bleeding and secondary infections. Distinguishing between hematoma and abscess is particularly challenging in this setting, as their clinical presentations often overlap. Early recognition through repeated imaging and timely intervention is therefore essential. We report the case of an 82-year-old man with COVID-19 pneumonia initially treated with dexamethasone, remdesivir, and antibiotics. His respiratory status worsened, prompting transfer to our hospital, where additional immunosuppressive therapy and anticoagulation were administered. During hospitalization, he developed acute right lower abdominal pain, and imaging revealed an iliopsoas hematoma, for which conservative management was chosen. He was later re-admitted with recurrent respiratory failure and diagnosed with organizing pneumonia requiring steroids. Subsequently, his oral intake declined, and further evaluation demonstrated a retroperitoneal mass with intralesional gas. Aspiration confirmed purulent fluid, establishing the diagnosis of an iliopsoas abscess. Drainage and antimicrobial therapy were initiated, resulting in gradual clinical improvement. This case underscores the diagnostic challenge of differentiating hematoma from abscess in elderly patients after COVID-19 and highlights the importance of vigilant follow-up.

Indexed as

80 and overagedcovid-19family medicinegeneral medicinehematoma/complicationsiliopsoas abscessiliopsoas muscles/pathologyimmunosuppressionrural

Identifiers

PMID41111659
PMCPMC12533940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.